Clinical trials
Orteq has completed enrolment in its European clinical trial to establish safety and performance for Actifit®. In July 2008, Actifit® received its CE mark and is now approved for sale in Europe.
If you are interested in more clinical information, please contact Dr Eva-Lisa Heinrichs, Chief Medical Officer, Orteq Ltd.
e-mail: CMO@orteq.com,
Telephone: +44 2078 682251
Orteq European Clinical Investigators
Professor René Verdonk is the Chief of the Orthopedic and Trauma Department at the University Hospital, Gent, Belgium. He is highly regarded around the world for his major research on the meniscus and transplantation of human meniscal allografts. Professor Verdonk is widely published on treatment of meniscal injuries. He is leading our first clinical trial in Europe.
rene.verdonk@ugent.be
Dr Peter Verdonk, UZ Gent, Gent, Belgium, peter.verdonk@ugent.be
Prof Hans Päessler, ATOS Clinic, Heidelberg, Germany
hans.paessler@atos.de
Dr Heinz Laprell, Chief of Trauma Surgery, Arthroscopy and Sports injury, Lubinus-Clinicum, Kiel, Germany.
hlaprell@lubinus-clinicum.de
Dr Phillipe Beaufils, Centre Hospitalier de Versailles, Versailles, France
pbeaufils@ch-versailles.fr
Prof Philippe Neyret, Centre Livet Hospital de la Rousse, Lyon , France
philippe.neyret@chu-lyon.fr
Dr Elvire Servien, Centre Livet Hospital de la Rousse, Lyon, France
elvire.servien@chu-lyon.fr
Dr Philippe Colombet, Merignac Clinic, Bordeaux, France
philippe.colombet5@wanadoo.fr
Dr Patrick Djian, Nollet Clinic, Brochant, Paris, France
djian@sofarthro.com
Patrick.djian@mac.com
Dr Ramon Cugat, Clinica del Pilar, Barcelona, Spain.
ramon.cugat@sportrauma.com
Prof Johan Bellemans, UZ Leuven, Leuven, Belgium.
Johan.bellemans@uz.kuleuven.ac.be